In 2022, the states with the highest rates of abortion per 1,000 women aged 15 to 44 years in the United States were New Mexico, Illinois, and Kansas. The states with the lowest rates of abortion were Missouri and South Dakota. Abortion differences among the states In 2022, the U.S. Supreme Court overturned Roe v. Wade allowing states to restrict the practice of abortion or outright ban it completely. A number of states immediately banned the procedure through trigger laws they had in place in anticipation of the ruling. Even before the ruling, abortion accessibility and rates varied greatly from state to state, but this difference has become even more pronounced. For example, in 2022, Florida had an abortion rate of 20.5 per 1,000 women, while the rate in Missouri was just .1. Florida had the highest total number of abortions that year, followed by New York and Illinois. While Florida reported around 82,581 abortions in 2022, there were just 88 such procedures in Missouri. Public opinion on abortion In the United States, the debate surrounding abortion is often divided among those who are “pro-life” and think abortion should be restricted or banned and those who are “pro-choice” and believe the decision to abort a pregnancy should be up to the woman. Gallup polls show the distribution of people in the United States who are pro-life or pro-choice has fluctuated over the years but in 2023 around 52 percent of respondents stated they were pro-choice while 44 percent said they were pro-life. Older respondents are more likely to express views limiting access to abortion, while younger people are more likely to believe abortion should be legal under any circumstance. However, just a small minority of people of all ages believe abortion should be illegal in all circumstances.

A survey of women who obtained an abortion in the United States between June 2021 and July 2022 found that 45 percent of women who received an abortion were insured under Medicaid, while 21 percent had no health insurance at all. This statistic shows the distribution of women in the U.S. who obtained an abortion from June 2021 to July 2022, by health insurance status.

ObjectiveTo determine which characteristics and circumstances were associated with very early and second-trimester abortion.MethodsPaper and pencil surveys were collected from a national sample of 8,380 non-hospital U.S. abortion patients in 2014 and 2015. We used self-reported LMP to calculate weeks gestation; when LMP was not provided we used self-reported weeks pregnant. We constructed two dependent variables: obtaining a very early abortion, defined as six weeks gestation or earlier, and obtaining second-trimester abortion, defined as occurring at 13 weeks gestation or later. We examined associations between the two measures of gestation and a range of characteristics and circumstances, including type of abortion waiting period in the patients’ state of residence.ResultsAmong first-trimester abortion patients, characteristics that decreased the likelihood of obtaining a very early abortion include being under the age of 20, relying on financial assistance to pay for the procedure, recent exposure to two or more disruptive events and living in a state that requires in-person counseling 24–72 hours prior to the procedure. Having a college degree and early recognition of pregnancy increased the likelihood of obtaining a very early abortion. Characteristics that increased the likelihood of obtaining a second-trimester abortion include being Black, having less than a high school degree, relying on financial assistance to pay for the procedure, living 25 or more miles from the facility and late recognition of pregnancy.ConclusionsWhile the availability of financial assistance may allow women to obtain abortions they would otherwise be unable to have, it may also result in delays in accessing care. If poor women had health insurance that covered abortion services, these delays could be alleviated. Since the study period, four additional states have started requiring that women obtain in-person counseling prior to obtaining an abortion, and the increase in these laws could slow down the trend in very early abortion.

This table contains 147 series, with data for years 1970 - 2000 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography, area of residence of patient (19 items: Total; area of residence of patient; Non-residents of Canada; Canada; area of residence of patient; Abortions reported by American states ...), Type of facility (3 items: Induced abortions; hospitals and clinics; Induced abortions; clinics; Induced abortions; hospitals ...), Characteristics (3 items: Number of induced abortions; Rate per 1;000 females aged 15 to 44;Ratio per 100 live births ...).

There is evidence from the United States that the legalisation of abortion has led to a significant reduction in neonatal and infant mortality. However, no research to date has been able to disentangle between effects of improved access to abortion at the household- and cohort-levels; there is no evidence for developing countries; and existing studies of the impact of abortion legalisation on early life health in the United States are not unanimous. Nepal initiated a drastic abortion reform in 2002. Moreover, because abortion facilities were made available to the public, the change in the law was not purely de jure. This research will collect data on local availability of abortion services, which opened at different times over a two-year period across the country. Combined with existing data sources, this information will allow estimating the effect of improved access to abortion more precisely, holding constant a number of potentially confounding factors. It will also compare neonatal mortality occurrence between siblings born before and those born after the opening of a nearby legal abortion centre, compare the effect on boys and girls, and estimate whether there is any evidence of improved access to abortion leading to sex-selective abortions. Comprehensive Abortion Care (CAC) provide legal abortion services in Nepal. Dates of CAC registration (i.e., official approval to carry out abortions) were obtained from official government records provided by the Ministry of Health, who also provided contact details for each of the 141 Comprehensive Abortion Care (CAC) centres registered by July 2006. Except for 2 of these 141 CACs, one which could not be reached, and one that did not appear to have ever existed after several checks, all were surveyed. A telephonic survey of all CAC facilities registered by July 2006 was carried out by the Center for Research on Environmental, Health and Population Activities (CREHPA), Kathmandu. Most interviews were completed from September to November 2009, but some more remote facilities could only be interviewed in January 2010 due to poor telephone connections.

BackgroundIn February 2011, an Ohio law took effect mandating use of the United States Food and Drug Administration (FDA)-approved protocol for mifepristone, which is used with misoprostol for medication abortion. Other state legislatures have passed or enacted similar laws requiring use of the FDA-approved protocol for medication abortion. The objective of this study is to examine the association of this legal change with medication abortion outcomes and utilization.Methods and FindingsWe used a retrospective cohort design, comparing outcomes of medication abortion patients in the prelaw period to those in the postlaw period. Sociodemographic and clinical chart data were abstracted from all medication abortion patients from 1 y prior to the law’s implementation (January 2010–January 2011) to 3 y post implementation (February 2011–October 2014) at four abortion-providing health care facilities in Ohio. Outcome data were analyzed for all women undergoing abortion at ≤49 d gestation during the study period. The main outcomes were as follows: need for additional intervention following medication abortion (such as aspiration, repeat misoprostol, and blood transfusion), frequency of continuing pregnancy, reports of side effects, and the proportion of abortions that were medication abortions (versus other abortion procedures). Among the 2,783 medication abortions ≤49 d gestation, 4.9% (95% CI: 3.7%–6.2%) in the prelaw and 14.3% (95% CI: 12.6%–16.0%) in the postlaw period required one or more additional interventions. Women obtaining a medication abortion in the postlaw period had three times the odds of requiring an additional intervention as women in the prelaw period (adjusted odds ratio [AOR] = 3.11, 95% CI: 2.27–4.27). In a mixed effects multivariable model that uses facility-months as the unit of analysis to account for lack of independence by site, we found that the law change was associated with a 9.4% (95% CI: 4.0%–18.4%) absolute increase in the rate of requiring an additional intervention. The most common subsequent intervention in both periods was an additional misoprostol dose and was most commonly administered to treat incomplete abortion. The percentage of women requiring two or more follow-up visits increased from 4.2% (95% CI: 3.0%–5.3%) in the prelaw period to 6.2% (95% CI: 5.5%–8.0%) in the postlaw period (p = 0.003). Continuing pregnancy was rare (0.3%). Overall, 12.6% of women reported at least one side effect during their medication abortion: 8.4% (95% CI: 6.8%–10.0%) in the prelaw period and 15.6% (95% CI: 13.8%–17.3%) in the postlaw period (p < 0.001). Medication abortions fell from 22% (95% CI: 20.8%–22.3%) of all abortions the year before the law went into effect (2010) to 5% (95% CI: 4.8%–5.6%) 3 y after (2014) (p < 0.001). The average patient charge increased from US$426 in 2010 to US$551 in 2014, representing a 16% increase after adjusting for inflation in medical prices. The primary limitation to the study is that it was a pre/post-observational study with no control group that was not exposed to the law.ConclusionsOhio law required use of a medication abortion protocol that is associated with a greater need for additional intervention, more visits, more side effects, and higher costs for women relative to the evidence-based protocol. There is no evidence that the change in law led to improved abortion outcomes. Indeed, our findings suggest the opposite. In March 2016, the FDA-protocol was updated, so Ohio providers may now legally provide current evidence-based protocols. However, this law is still in place and bans physicians from using mifepristone based on any new developments in clinical research as best practices continue to be updated.

Administrative claims and electronic health records are valuable resources for evaluating pharmaceutical effects during pregnancy. However, direct measures of gestational age are generally not available. Establishing a reliable approach to infer the duration and outcome of a pregnancy could improve pharmacovigilance activities. We developed and applied an algorithm to define pregnancy episodes in four observational databases: three US-based claims databases: Truven MarketScan® Commercial Claims and Encounters (CCAE), Truven MarketScan® Multi-state Medicaid (MDCD), and the Optum ClinFormatics® (Optum) database and one non-US database, the United Kingdom (UK) based Clinical Practice Research Datalink (CPRD). Pregnancy outcomes were classified as live births, stillbirths, abortions and ectopic pregnancies. Start dates were estimated using a derived hierarchy of available pregnancy markers, including records such as last menstrual period and nuchal ultrasound dates. Validation included clinical adjudication of 700 electronic Optum and CPRD pregnancy episode profiles to assess the operating characteristics of the algorithm, and a comparison of the algorithm’s Optum pregnancy start estimates to starts based on dates of assisted conception procedures. Distributions of pregnancy outcome types were similar across all four data sources and pregnancy episode lengths found were as expected for all outcomes, excepting term lengths in episodes that used amenorrhea and urine pregnancy tests for start estimation. Validation survey results found highest agreement between reviewer chosen and algorithm operating characteristics for questions assessing pregnancy status and accuracy of outcome category with 99–100% agreement for Optum and CPRD. Outcome date agreement within seven days in either direction ranged from 95–100%, while start date agreement within seven days in either direction ranged from 90–97%. In Optum validation sensitivity analysis, a total of 73% of algorithm estimated starts for live births were in agreement with fertility procedure estimated starts within two weeks in either direction; ectopic pregnancy 77%, stillbirth 47%, and abortion 36%. An algorithm to infer live birth and ectopic pregnancy episodes and outcomes can be applied to multiple observational databases with acceptable accuracy for further epidemiologic research. Less accuracy was found for start date estimations in stillbirth and abortion outcomes in our sensitivity analysis, which may be expected given the nature of the outcomes.

The 1996 Uzbekistan Demographic and Health Survey (UDHS) is a nationally representative survey of 4,415 women age 15-49. Fieldwork was conducted from June to October 1996. The UDHS was sponsored by the Ministry of Health (MOH), and was funded by the United States Agency for International Development. The Institute of Obstetrics and Gynecology implemented the survey with technical assistance from the Demographic and Health Surveys (DHS) program. The 1996 UDHS was the first national-level population and health survey in Uzbekistan. It was implemented by the Research Institute of Obstetrics and Gynecology of the Ministry of Health of Uzbekistan. The 1996 UDHS was funded by the United States Agency for International development (USAID) and technical assistance was provided by Macro International Inc. (Calverton, Maryland USA) through its contract with USAID. OBJECTIVES AND ORGANIZATION OF THE SURVEY The purpose of the 1996 Uzbekistan Demographic and Health Survey (UDHS) was to provide an information base to the Ministry of Health for the planning of policies and programs regarding the health of women and their children. The UDHS collected data on women's reproductive histories, knowledge and use of contraception, breastfeeding practices, and the nutrition, vaccination coverage, and episodes of illness among children under the age of three. The survey also included, for all women of reproductive age and for children under the age of three, the measurement of the hemoglobin level in the blood to assess the prevalence of anemia and measurements of height and weight to assess nutritional status. A secondary objective of the survey was to enhance the capabilities of institutions in Uzbekistan to collect, process and analyze population and health data so as to facilitate the implementation of future surveys of this type. MAIN RESULTS Fertility Rates. Survey results indicate a total fertility rate (TFR) for all of Uzbekistan of 3.3 children per woman. Fertility levels differ for different population groups. The TFR for women living in urbml areas (2.7 children per woman) is substantially lower than for women living in rural areas (3.7). The TFR for Uzbeki women (3.5 children per woman) is higher than for women of other ethnicities (2.5). Among the regions of Uzbekistan, the TFR is lowest in Tashkent City (2.3 children per woman). Family Planning. Knowledge. Knowledge of contraceptive methods is high among women in Uzbekistan. Knowledge of at least one method is 89 percent. High levels of knowledge are the norm for women of all ages, all regions of the country, all educational levels, and all ethnicities. However, knowledge of sterilization was low; only 27 percent of women reported knowing of this method. Fertility Preferences. A majority of women in Uzbekistan (51 percent) indicated that they desire no more children. Among women age 30 and above, the proportion that want no more children increases to 75 percent. Thus, many women come to the preference to stop childbearing at relatively young ages when they have 20 or more potential years of childbearing ahead of them. For some of these women, the most appropriate method of contraception may be a long-acting method such as female sterilization, However, there is a deficiency of both knowledge and use of this method in Uzbekistan. In the interest of providing couples with a broad choice of safe and effective methods, information about this method and access to it should be made available so that informed choices about its suitability can be made by individual women and couples. Induced Aboration : Abortion Rates. From the UDHS data, the total abortion rate (TAR)the number of abortions a woman will have in her lifetime based on the currently prevailing abortion rateswas calculated. For Uzbekistan, the TAR for the period from mid-1993 to mid-1996 is 0.7 abortions per woman. As expected, the TAR for Uzbekistan is substantially lower than recent estimates of the TAR for other areas of the former Soviet Union such as Kazakstan (1.8), Romania (3.4 abortions per woman), and Yekaterinburg and Perm in Russia (2.3 and 2.8, respectively). Infant mortality : In the UDHS, infant mortality data were collected based on the international definition of a live birth which, irrespective of the duration of pregnancy, is a birth that breathes or shows any sign of life (United Nations, 1992). Mortality Rates. For the five-year period before the survey (i.e., approximately mid- 1992 to mid- 1996), infant mortality in Uzbekistan is estimated at 49 infant deaths per 1,000 births. The estimates of neonatal and postneonatal mortality are 23 and 26 per 1,000. Maternal and child health : Uzbekistan has a well-developed health system with an extensive infrastructure of facilities that provide maternal care services. This system includes special delivery hospitals, the obstetrics and gynecology departments of general hospitals, women's consulting centers, and doctor's assistant/midwife posts (FAPs). There is an extensive network of FAPs throughout rural areas. Nutrition : Breastfeeding. Breastfeeding is almost universal in Uzbekistan; 96 percent of children born in the three years preceding the survey are breastfed. Overall, 19 percent of children are breastfed within an hour of delivery and 40 percent within 24 hours of delivery. The median duration of breastfeeding is lengthy (17 months). However, durations of exclusive breastfeeding, as recommended by WHO, are short (0.4 months). Prevalence of anemia : Testing of women and children for anemia was one of the major efforts of the 1996 UDHS. Anemia has been considered a major public health problem in Uzbekistan for decades. Nevertheless, this was the first anemia study in Uzbekistan done on a national basis. The study involved hemoglobin (Hb) testing for anemia using the Hemocue system. Women. Sixty percent of the women in Uzbekistan suffer from some degree of anemia. The great majority of these women have either mild (45 percent) or moderate anemia (14 percent). One percent have severe anemia.

CDC began abortion surveillance in 1969 to document the number and characteristics of women obtaining legal induced abortions. Many states and reporting areas (New York City and the District of Columbia) conduct abortion surveillance. CDC compiles the information these reporting areas collect to produce national estimates. CDC’s surveillance system compiles information on legal induced abortions only. For the purpose of surveillance, a legal induced abortion is defined as an intervention performed by a licensed clinician (e.g., a physician, nurse-midwife, nurse practitioner, or physician assistant) that is intended to terminate an ongoing pregnancy. Most states and reporting areas that collect abortion data now report if an abortion was medical or surgical. Medical abortions are legal procedures that use medications instead of surgery.

Number of teen pregnancies and rates per 1,000 females, by pregnancy outcome (live births, induced abortions, or fetal loss), by age groups 15 to 17 years and 18 to 19 years, 1998 to 2000.

This study examines the psychological outcomes of therapeutic abortion during the period immediately preceding the U.S. Supreme Court decision invalidating restrictive abortion laws. The sample was drawn from women requesting abortions at a large urban hospital in the northeast. The participants were interviewed by a psychiatrist before the abortion, 24 hours after the procedure, and at six weeks and six months postabortion. One hundred and two women participated in the study, 84 of whom participated in all four interviews. Background data available includes demographic information, marital history, data on the parents and spouse, and emotional and medical history. Extensive clinical interviews were conducted at each of the four sessions. These covered the following topics: history of contraception, conception, and pregnancy; reasons for seeking abortion; ambivalence; past medical and emotional history; sexual behavior; object relationships; dreams; doubt, guilt, anger, shame, and general mood states; predictions; diagnostic formulations; and changes in activities and life situation of the subject. Participants also completed the Minnesota Multiphasic Personality Inventory (MMPI) at the first and fourth testing times, and the Profile of Mood States (POMS) and Symptoms Rating Scale (SRS) at all four testing times. Some participants also completed the scales for femininity, socialization, and modernity from the California Personality Inventory (CPI) at the first and fourth meetings. The Murray Archive holds copies of all paper data from the study. The Murray Archive also holds doctors' reports of initial interviews with approximately 2,300 additional patients who requested therapeutic abortions between 1969 and 1974. If you would like to access this material, please apply to use the data.

Multivariable model of characteristics associated with additional interventions following medication abortions up to 49 d (n = 2,783).

A nationally representative sample of the US adult population was surveyed in June of 2014. GfK Knowledge Networks, a survey research firm, recruited participants from their probability-based internet panel, KnowledgePanel, which represents 97% of U.S. households. See http://www.knowledgenetworks.com/ganp/docs/KnowledgePanel(R)-Design-Summary.pdf for additional details about the design of the panel and GfK's methodology. The survey was designed to explore the effect of "non-welfare interests" (NWIs) on the public's willingness to donate to a biobank. Non-welfare interests refers to the moral, religious, or cultural concerns that potential donors may have with how their donated biospecimens could be used. Respondents were presented with 7 NWI research scenarios (e.g. research to make abortions safer and more effective) and were then asked whether they would be willing to provide blanket (or broad) consent knowing such research might be conducted. The survey also asked about respondents' preferences for 5 biobank consent policies, ranging from blanket (or broad) consent to real-time specific (or study-by-study) consent. A variety of additional sociodemographic and attitudinal data were collected, including responses to the Research Attitudes Questionnaire (RAQ)--a measure of trust in medical research. The final dataset includes 1,599 responses, a response rate of 60.2%.